
|

| |
Track this Pro and follow
their portfolio moves with tickerspy™ alerts |
 |
|
 | Argenis Capital Advisors, LLC |
| |
Performance |
|
|
|
Similar Pro Portfolios |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
0.0%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.7%
|
Data since: Apr-1-2008 Current Portfolio: Q2 2008
|
|
|
|
|
| Not enough data to generate similar portfolios. Please check back later. |
|
|
|
|
Share this Pro on Facebook
Share this Pro on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

 |
Click
a column to sort | Scroll over columns for more information |
|
|
| BIIB |
$233.07 |
+1.74 |
+0.75% |
1,404,856 |
102% |
$54.9B |
- |
84% |
-1% |
+292.8% |
$1.5M | 24.5K shares - New Holding
2 Alerts (0 News) - View
|
|
|
| BIOD |
$3.62 |
+0.19 |
+5.54% |
271,161 |
357% |
$48.7M |
- |
70% |
-5% |
-70.8% |
$1.0M | 70.3K shares - New Holding
No Alerts/News
|
|
|
| CELG |
$123.44 |
-0.06 |
-0.05% |
4,199,827 |
126% |
$51.6B |
- |
111% |
-6% |
+78.2% |
$1.1M | 17.0K shares - New Holding
No Alerts/News
|
|
|
| CYCC |
$2.99 |
-0.08 |
-2.61% |
605,857 |
249% |
$33.2M |
- |
2% |
-63% |
+51.0% |
$1.7M | 646.0K shares - decrease of 134.1K shares
3 Alerts (1 News) - View
|
|
|
| ESRX |
$62.49 |
+1.18 |
+1.92% |
8,216,056 |
154% |
$50.1B |
- |
26% |
-5% |
+98.4% |
$686.3K | 10.0K shares - New Holding
No Alerts/News
|
|
|
| HLS |
$30.19 |
-0.21 |
-0.69% |
619,045 |
117% |
$2.6B |
- |
64% |
-2% |
+83.4% |
$885.4K | 46.5K shares - New Holding
No Alerts/News
|
|
|
| HUM |
$79.17 |
-0.35 |
-0.44% |
1,229,537 |
55% |
$12.5B |
1.4% |
32% |
-4% |
+97.6% |
$681.8K | 15.0K shares - New Holding
No Alerts/News
|
|
|
| INCY |
$22.32 |
+0.06 |
+0.27% |
1,235,415 |
118% |
$3.0B |
- |
45% |
-15% |
+194.8% |
$996.6K | 101.0K shares - increase of 96.0K shares
No Alerts/News
|
|
|
| NKTR |
$9.24 |
-0.49 |
-5.04% |
1,888,638 |
199% |
$1.1B |
- |
64% |
-19% |
+176.6% |
$596.7K | 126.0K shares - New Holding
1 Alert (0 News) - View
|
|
|
| NUVA |
$22.57 |
-0.57 |
-2.46% |
376,912 |
102% |
$1.0B |
- |
83% |
-13% |
-49.6% |
$1.3M | 33.0K shares - New Holding
No Alerts/News
|
|
|
| SHPG |
$97.04 |
+0.10 |
+0.10% |
1,006,332 |
121% |
$18.1B |
0.5% |
21% |
-5% |
+104.0% |
$1.3M | 24.0K shares - New Holding
No Alerts/News
|
|
|
| SQNM |
$3.91 |
-0.15 |
-3.69% |
2,162,762 |
84% |
$467.5M |
- |
48% |
-27% |
-76.0% |
$923.2K | 104.5K shares - decrease of 324.9K shares
No Alerts/News
|
|
|
| VAR |
$68.43 |
-1.45 |
-2.07% |
730,985 |
74% |
$7.5B |
- |
29% |
-10% |
+34.3% |
$960.8K | 20.0K shares - New Holding
No Alerts/News
|
|
|
| [DNA] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$1.6M | 22.5K shares - New Holding
1 Alert (0 News) - View
|
|
|
| [MHS] |
$0.00 |
0.00 |
0.00% |
|
0% |
$ |
- |
N/A% |
N/A% |
-100.0% |
$1.1M | 22.5K shares - New Holding
No Alerts/News
|
|
|
|
|
Discuss Argenis Capital Advisors, LLC's portfolio
|
|
|
|
| |

|
| |
|
| |

|
| |
Cyclacel Pharmaceuticals Announces Closing of Underwritten Offering CYCC CYCCP
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 21, 04:13PM from (globenewswire.com) BERKELEY HEIGHTS, N.J., May 21, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel
Flag
Post a comment
Teva Bets on Reformulating Old Drugs as Investors Say 'Show Me' BMY FRX LLY JNJ BIIB ALXA
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 21, 07:01AM from (www.bloomberg.com) Teva Pharmaceutical Industries Ltd. (TEVA), which just two years ago was analysts’ highest-rated stock among the world’s
Flag
Post a comment
'Love Hormone' Promises Safer Births After Pfizer Flop PFE MNKD NKTR
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 19, 06:03PM from (www.bloomberg.com) A hormone treatment based on technology used in Pfizer Inc. (PFE)’s failed inhalable insulin shows promise in fighting the leading cause of maternal mortality.
Flag
Post a comment
A Data Trove Now Guides Drug Company Pitches HUM
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - May 16, 01:28PM from (www.nytimes.com) Databases allow pharmaceutical companies to know what drugs a doctor prescribes, whether the patient is taking them and often
Flag
Post a comment
Top New Biotech Ideas from PropThink CELG REGN CBST VPHM ONXX AVEO MAKO
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 16, 07:30AM from (247wallst.com) The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA)
Flag
Post a comment
Deutsche Bank Firm on Biotech Stocks to Buy AMGN CELG REGN BIIB VRTX GILD ALXN ONXX DB
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 15, 08:10AM from (247wallst.com) Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and
Flag
Post a comment
Cyclacel Reports First Quarter 2013 Financial Results CYCC CYCCP
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 13, 04:13PM from (globenewswire.com) BERKELEY HEIGHTS, N.J., May 13, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel
Flag
Post a comment
Six Hot Stocks to Watch for Friday: Gap, 3D Systems, Pain Therapeutics and More GPS PGNX DDD PTIE SQNM UBNT
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 10, 09:20AM from (247wallst.com) It is Friday, so TGIF. Before you get too deep into your weekend there is still a full trading day and Wall Street has many
Flag
Post a comment
S&P Highlights Biotech ETFs ABT JNJ AMGN CELG BIIB VRTX GILD NPSP IBB BBH PJP XBI
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - May 10, 07:39AM from (www.benzinga.com) Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at
Flag
Post a comment
Cyclacel Pharmaceuticals to Announce Release of First Quarter 2013 Financial Results CYCC CYCCP
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 07:13AM from (globenewswire.com) BERKELEY HEIGHTS, N.J., May 10, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel
Flag
Post a comment
Humana Appoints Roy A. Beveridge, M.D., as Chief Medical Officer HUM
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 08:45AM from (www.businesswire.com) Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today that Roy A. Beveridge,
Flag
Post a comment
Biodel Reports Second Quarter Fiscal Year 2013 Financial Results BIOD
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 07:43AM from (globenewswire.com) DANBURY, Conn., May 8, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (Nasdaq:BIOD) today reported financial results for the second
Flag
Post a comment
|
|